Literature DB >> 6760399

Quantitation of renal function with glomerular and tubular agents.

E V Dubovsky, C D Russell.   

Abstract

Quantitative methods to measure the glomerular and tubular function of the kidneys with radionuclides have been available for many years. They have not been widely used because the techniques and the calculations exceeded the scope of routine nuclear medicine practice. Validation of simplified methods and the introduction of computer technology have made measurement of the effective renal plasma flow (ERPF) and the glomerular filtration rate (GFR) simple enough so that they can be performed reproducibly in most nuclear medicine departments. The estimation of ERPF with radioiodinated OIH and GFR with 99mTcDTPA can be achieved in many ways, all of which yield clinically useful results. How to get the best results using the simplest methods is still unclear. The required accuracy depends on the intended clinical use. Our preference at the present time is to use a single or double plasma sample to calculate global ERPF or GFR, and to use the 1-2 min OIH or 1-3 min Tc-DTPA uptake to calculate relative function of the two kidneys (split function ERPF or GFR). The choice of method will be influenced by local factors, such as the nature of the patient population, the case volume, and the resources available. A desirable goal for future studies is to document carefully the capabilities and limitations of each alternative method, so that the choice can be rational.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760399     DOI: 10.1016/s0001-2998(82)80013-5

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  14 in total

1.  Limitations of clearance determination using the single sample distribution volume method. An error analysis on the basis of compartment models.

Authors:  J Kotzerke; W Burchert; H Wiese; U von Smekal; H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1992

2.  Dynamic renogram with 99mTc DTPA in patient with adult polycystic kidney disease.

Authors:  Irina Mezheritskiy; Gary Stuart Greene
Journal:  BMJ Case Rep       Date:  2010-03-08

3.  Nuclear medicine-important advances in clinical medicine: noninvasive evaluation of obstructive versus nonobstructive uropathy.

Authors:  M G McCalley; P Braunstein
Journal:  West J Med       Date:  1983-11

4.  The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.

Authors:  Anna Yordanova; Anja Becker; Elisabeth Eppard; Stefan Kürpig; Christian Fisang; Georg Feldmann; Markus Essler; Hojjat Ahmadzadehfar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-23       Impact factor: 9.236

5.  Evaluation of autosomal dominant polycystic kidney disease by DTPA renal scintigraphy.

Authors:  M Vlajković; A Slavković; S Ilić; M Popović; V Stefanović
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

6.  The incidence and clinical features of acute kidney injury secondary to ureteral calculi.

Authors:  Si-Jun Wang; Xiao-Nan Mu; Long-Yang Zhang; Qing-Yong Liu; Xun-Bo Jin
Journal:  Urol Res       Date:  2011-08-19

7.  Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?

Authors:  Jillian MacAulay; Kara Thompson; Bryce A Kiberd; David C Barnes; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

8.  Serial measurement of renal plasma flow.

Authors:  K G Leach; H F Slowey; M Rosen; A W Asscher
Journal:  Eur J Nucl Med       Date:  1985

9.  Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.

Authors:  Stephen A Contag; Jianli Bi; Mark C Chappell; James C Rose
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-13

Review 10.  Imaging techniques in the evaluation of pediatric hypertension.

Authors:  M J Siegel; T E St Amour; B A Siegel
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.